We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

117 hedge funds and large institutions have $19.2M invested in Sanofi Contingent Value Rights in 2015 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% more funds holding

Funds holding: 116 → 117 (+1)

0% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 21

71% less capital invested

Capital invested by funds: $66.6M → $19.2M (-$47.4M)

Holders
117
Holders Change
+1
Holders Change %
+0.86%
% of All Funds
3.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
11
Increased
21
Reduced
21
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Stonehill Capital Management
New York
+$662K
2
GCM
Gruss Capital Management
New York
+$510K
3
PC
Pomelo Capital
New York
+$416K
4
WA
Whitebox Advisors
Minnesota
+$365K
5
DAM
Deltec Asset Management
New York
+$295K

Top Sellers

Rank Fund Capital Flow
1
PWAM
Park West Asset Management
California
-$428K
2
CPA
Columbia Pacific Advisors
Washington
-$166K
3
MCM
Moore Capital Management
New York
-$83.4K
4
IRF
IBM Retirement Fund
New York
-$49K
5
Millennium Management
Millennium Management
New York
-$41K
Name Holding Trade Value Shares
Change 		Change in
Stake
KAM
51
Knightsbridge Asset Management
California
$5K -$10.5K -30,800 -53%
PP
52
Pegasus Partners
Wisconsin
$4K – – –
OC
53
Oppenheimer & Co
New York
$3K -$3.23K -9,490 -33%
BIA
54
Biondo Investment Advisors
Pennsylvania
$3K -$51 -150 -0.9%
HK
55
Horizon Kinetics
New York
$3K – – –
MC
56
Moors & Cabot
Massachusetts
$3K – – –
RL
57
Ruffer LLP
United Kingdom
$3K – – –
TSS
58
Two Sigma Securities
New York
$3K +$5.15K +15,153 New
GWM
59
Gupta Wealth Management
California
$3K +$5.56K +16,353 New
CS
60
Credit Suisse
Switzerland
$3K +$6.04K +17,768 New
PNC Financial Services Group
61
PNC Financial Services Group
Pennsylvania
$2K -$92 -270 -2%
BlackRock
62
BlackRock
New York
$2K – – –
DA
63
Dillon & Associates
Michigan
$2K – – –
LPL Financial
64
LPL Financial
California
$2K +$68 +199 +2%
BNP Paribas Financial Markets
65
BNP Paribas Financial Markets
France
$1.04K – – –
LTFS
66
Ladenburg Thalmann Financial Services
Florida
$1K -$340 -1,000 -18%
Bank of Montreal
67
Bank of Montreal
Ontario, Canada
$1K – – –
Deutsche Bank
68
Deutsche Bank
Germany
$1K – – –
CTC
69
Central Trust Company
Missouri
$1K +$177 +520 +12%
Creative Planning
70
Creative Planning
Kansas
$1K +$919 +2,703 New
SIM
71
Sonora Investment Management
Arizona
$1K +$1.03K +3,028 New
WEC
72
Winslow Evans & Crocker
Massachusetts
$264 – – –
SAM
73
Silverback Asset Management
North Carolina
$176 -$34.7K -102,100 -10%
MPWT
74
MassMutual Private Wealth & Trust
Connecticut
$7 – – –
ECM
75
Estabrook Capital Management
New York
$3 – – –
1 2
3
4

GCVRZ Hedge Fund Activity: Q3 2015 in Review

117 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q3 2015, worth a combined $19.2M — down 71% from $66.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new GCVRZ positions and 10 closed out — a net gain of 1 holder — while 21 added to existing stakes and 21 trimmed.

The largest buyer was Stonehill Capital Management, opening a new position worth an estimated $662K. The largest seller was Park West Asset Management, exiting entirely with an estimated $428K sold.

  • 117 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q3 2015, up from 116 in Q2 2015.
  • Funds reported $19.2M of Sanofi Contingent Value Rights stock for Q3 2015, down 71% quarter-over-quarter.
  • 11 funds opened new Sanofi Contingent Value Rights positions in Q3 2015 and 10 closed out, a net change of +1 holder.
  • The largest Sanofi Contingent Value Rights buyer in Q3 2015 was Stonehill Capital Management, an estimated $662K added.
  • The largest Sanofi Contingent Value Rights seller in Q3 2015 was Park West Asset Management, an estimated $428K sold.

Based on aggregated 13F filings for Q3 2015.